Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Ironwood Pharmaceuticals (IRWD) over the last 14 years, with Q3 2025 value amounting to 1.48.

  • Ironwood Pharmaceuticals' Debt Ratio rose 4371.25% to 1.48 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.48, marking a year-over-year increase of 4371.25%. This contributed to the annual value of 1.1 for FY2024, which is 345.89% up from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Debt Ratio is 1.48, which was up 4371.25% from 1.7 recorded in Q2 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Debt Ratio peaked at 1.7 during Q2 2025, and registered a low of 0.1 during Q4 2021.
  • Its 5-year average for Debt Ratio is 0.87, with a median of 1.04 in 2024.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Debt Ratio soared by 264.02% in 2024 and then skyrocketed by 5860.73% in 2025.
  • Quarter analysis of 5 years shows Ironwood Pharmaceuticals' Debt Ratio stood at 0.1 in 2021, then grew by 7.33% to 0.11 in 2022, then surged by 852.8% to 1.06 in 2023, then increased by 3.46% to 1.1 in 2024, then soared by 34.51% to 1.48 in 2025.
  • Its Debt Ratio was 1.48 in Q3 2025, compared to 1.7 in Q2 2025 and 1.18 in Q1 2025.